Common TitleMaxCmin2
Official Title A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial
Phase Phase IV
Categories Treatment-NaiveTreatment-Experienced
Funding
IndustryRoche Pharmaceutical Ltd.
References
- Dragsted UB, Gerstoft J, Youle M, et al. A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial. Antivir Ther. 2005;10:735-43.